abstract |
The present invention provides an effective therapeutic method for treating or preventing a disease or disorder associated with α-ENaC. The present invention relates to compositions and methods for modulating the expression of α-ENaC, and more particularly to down-regulation of α-ENaC expression by chemically modified oligonucleotides. [Selection figure] None |